New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
18:35 EDTTXMD, BWLD, YELP, TRN, NUVA, X, ECYT, ZLTQ, AFL, ICPT, WB, AMGN, SQNM, EXAM, RNG, PNRA, MOVE, FB, TWTR, NCR, EW, AEGR, RUBIOn The Fly: After Hours Movers
UP AFTER EARNINGS: Panera Bread (PNRA), up 1.3%... Zeltiq Aesthetics (ZLTQ), up 28.1%... Rubicon Project (RUBI), up 12.5%... RingCentral (RNG), up 11%... Endocyte (ECYT), up 10.5%... Aegerion Pharmaceuticals (AEGR), up 9.4%... Examworks (EXAM), up 8.8%... U.S. Steel (X), up 7.3%... Edwards Lifesciences (EW), up 7.2%... Sequenom (SQNM), up 7.5%... NuVasive (NUVA), up 5.6%... NCR Corp. (NCR), up 3.5%... Amgen (AMGN), up 4% after reporting quarterly results and announcing that it will reduce its global workforce by 12%-15%... Trinity Industries (TRN), up 2.8%... Twitter (TWTR), up 29.1% after reporting better than expected second quarter results as well as third quarter and fiscal 2014 guidance above analyst expectations. NOTABLE: Weibo Corp (WB), up 5.5%; Yelp (YELP), up 3.6%; Facebook (FB), up just under 1%, respectively, following Twitter's second quarter results. ALSO HIGHER: Intercept Pharmaceuticals (ICPT), up 2.5% following upgrade to Buy from Neutral at Nomura. DOWN AFTER EARNINGS: Buffalo Wild Wings (BWLD), down 10.6%... Move Inc. (MOVE), down 3.5%... Aflac (AFL), down 4% after reporting second quarter results and guidance for third quarter and fiscal 2014. ALSO LOWER: TherapeuticsMD (TXMD), down marginally after filing to sell $40M in common stock.
News For PNRA;ZLTQ;RUBI;RNG;ECYT;AEGR;EXAM;X;EW;SQNM;NUVA;NCR;AMGN;TRN;TWTR;WB;YELP;FB;ICPT;BWLD;MOVE;AFL;TXMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
November 11, 2014
10:00 EDTRNGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTNUVAOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alcentra Capital (ABDC) upgraded to Outperform from Market Perform at Keefe Bruyette... Ambac Financial (AMBC) upgraded to Neutral from Sell at MKM Partners... Banco Bilbao (BBVA) upgraded to Buy from Reduce at Nomura... Darden (DRI) upgraded at KeyBanc... ICU Medical (ICUI) upgraded to Overweight from Neutral at Piper Jaffray... IMAX (IMAX) upgraded to Buy from Neutral at Goldman... Juniper (JNPR) upgraded to Buy from Neutral at Nomura... Michaels (MIK) upgraded to Overweight from Equal Weight at Morgan Stanley... Midcoast Energy (MEP) upgraded to Outperform from Neutral at Credit Suisse... Midstates Petroleum (MPO) upgraded to Outperform from Market Perform at Northland... Monroe Capital (MRCC) upgraded to Outperform from Neutral at RW Baird... NuVasive (NUVA) upgraded to Outperform from Market Perform at Cowen... ONEOK Partners (OKS) upgraded to Outperform from Neutral at Credit Suisse... ORBCOMM (ORBC) upgraded to Overweight from Equal Weight at First Analysis... Pattern Energy (PEGI) upgraded to Outperform from Neutral at Macquarie... Targa Resources Partners (NGLS) upgraded to Outperform from Neutral at Credit Suisse... Time Warner (TWX) upgraded to Conviction Buy from Neutral at Goldman... Tremor Video (TRMR) upgraded to Buy from Hold at Jefferies... Western Gas Partners (WES) upgraded to Outperform from Neutral at Credit Suisse... Yamana Gold (AUY) upgraded to Overweight from Neutral at HSBC... Zynga (ZNGA) upgraded to Buy from Hold at Jefferies.
09:37 EDTTWTRActive equity options trading
Subscribe for More Information
08:53 EDTAEGRAegerion says SEC issues request for information to specialty pharmacy entity
Subscribe for More Information
08:10 EDTNUVANuVasive upgraded to Outperform from Market Perform at Cowen
As previously reported, Cowen upgraded NuVasive to Outperform from Market Perform. The analyst believes NuVasive is well positioned for share gains from innovative offerings and to beat modestly improving Spine market growth rates. Price target raised to $51 from $44.
07:51 EDTNUVANuVasive upgraded to Outperform from Market Perform at Cowen
06:11 EDTRNGRingCentral initiated with an Outperform at Macquarie
Target $16.
November 10, 2014
18:15 EDTTWTRTwitter CEO, others sell $10.58M shared in planned sale, Barron's says
Subscribe for More Information
16:00 EDTTWTROptions Update; November 10, 2014
Subscribe for More Information
15:54 EDTAMGNAmerican Society of Nephrology to hold a conference
Subscribe for More Information
15:53 EDTECYTCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
13:54 EDTNUVANuVasive to host investor meeting
Subscribe for More Information
12:53 EDTFBFacebook says has over 50M monthly active users for Messenger
Subscribe for More Information
10:48 EDTFBFacebook enhances users' control over News Feeds
Facebook on Friday announced that News Feed settings will now show a list of the top people, Pages and Groups that users have seen in their News Feeds over the past week. Users can choose to sort by people, Pages or Groups posts, or see an overall summary., the social network said. They can unfollow any friend, Page or Group if they donít want to see their stories in their News Feeds, Facebook added. Users can also see who theyíve unfollowed in the past and can choose to re-follow them at anytime, the company stated. If users see a story they're not interested in or donít want to see, they can tap the arrow in the top right of that story to hide it, Facebook said. Reference Link
09:35 EDTFB, XActive equity options trading
Subscribe for More Information
08:36 EDTICPTIntercept price target lowered to $125 from $172 at FBR Capital
FBR Capital lowered its price target for Intercept shares to $125 saying its talks with experts and cardiologists indicate the company's OCA drug is unlikely to be a "silver bullet" for the treatment of nonalcoholic steatohepatitis. FBR notes that while OCA appears to improve the liver, the drug worsens many of the other derangements like lipid and glucose homeostasis. FBR decreased the probability of success in NASH to 55% from 60%, and lowered its peak OCA sales estimate to $5.2B. It keeps an Underperform rating on Intercept shares.
08:05 EDTNCRNCR Silver POS to support bitcoin
Subscribe for More Information
07:23 EDTYELPRBC Capital to hold a conference
Subscribe for More Information
07:12 EDTAFL, TWTRCA Technologies to hold a conference
CA World 2014 is being held in Las Vegas on November 9-12.
07:08 EDTAFLCredit Suisse to hold a conference
2014 Boston Financials 1:1 Conference to be held in Boston on November 10-11.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use